Imaginatik PLC Contracts win
February 16 2015 - 1:01AM
RNS Non-Regulatory
TIDMIMTK
Imaginatik PLC
16 February 2015
16 February 2015
RNS Reach
Imaginatik Plc
("Imaginatik" or the "Company")
Contracts win
Imaginatik plc (AIM: IMTK.L), the world's first full service
innovation provider offering a range of technology products and
consultancy services, is pleased to announce that, following the
trading update on 11 February 2015, it has signed two further
contracts, one with a leading US based biotech company and the
other with a leading Canadian media service, both of which have an
initial one year term.
Under the terms of the contract with the US biotech company,
Imaginatik will provide its consulting expertise and technology
platforms in order to support the customer in initiating its own
innovation programme. Imaginatik will help catalyse, develop and
incorporate innovation capabilities across the business, enabling
the customer to adjust efficiently to its evolving and dynamic
marketplace.
Additionally Imaginatik will provide the technology platform and
consulting support to the Canadian media service as they look to
upgrade from a previous platform provider as they seek to expand
and enhance their innovation strategy.
Matt Cooper, Non-Executive Chairman, commented: "I am delighted
to announce that we are able to further increase our customer base
and both these new contracts demonstrate the high quality offering
and added value that we can deliver to our customers. We look
forward to working with and expanding our reach across the biotech
industry. In addition, we will support the Canadian media service
in committing to Imaginatik's full platform and through this we
will help catalyse and build a sustainable innovation competency
within the organisation to capture new sources of value."
"These additional contract wins demonstrate that our approach
and expertise continue to offer significant benefits to our
customers, and enable them to develop and enhance their innovation
competencies through capturing new sources of value regarding
business and growth strategies."
For further information please contact:
Imaginatik plc 01329 243243
Matt Cooper - Executive Chairman
Ralph Welborn - CEO
Shawn Taylor - CFO
finnCap Ltd 0207 220 0500
Charlotte Stranner/ Victoria Bates
Newgate Threadneedle 020 7653 9850
Adam Lloyd / Edward Treadwell / Jasper
Randall
About Imaginatik
Imaginatik(R) is the world's first full-service innovation
provider. We have 16 years of experience building innovation into a
sustainable competence at some of the world's largest and most
respected companies. Through a mix of consulting and advisory,
hands-on innovation projects and program management, and our
award-winning enterprise software platform, we help clients develop
innovation capability into a permanent competitive advantage.
Imaginatik is the trusted partner of leading organisations
including Blue Cross Blue Shield, CSC, Cargill, The World Bank,
Mayo Clinic, The Chubb Group of Insurance Companies, HCA, Dow
Chemical and Goodyear.
Imaginatik is a public company whose shares are traded on the
AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World
Economic Forum Technology Pioneer with offices in Boston, MA, and
Fareham, UK. For more information visit www.imaginatik.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAZMGMZGKLGKZZ
Abal (LSE:ABAL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Abal (LSE:ABAL)
Historical Stock Chart
From Jul 2023 to Jul 2024